
Fortrea Holdings (FTRE) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
651.3M
Gross Profit
116.5M
17.89%
Operating Income
-24.8M
-3.81%
Net Income
-562.9M
-86.43%
EPS (Diluted)
$-6.25
Balance Sheet Metrics
Total Assets
3.1B
Total Liabilities
2.3B
Shareholders Equity
858.8M
Debt to Equity
2.63
Cash Flow Metrics
Operating Cash Flow
-620.6M
Free Cash Flow
-127.1M
Revenue & Profitability Trend
Fortrea Holdings Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 2.7B | 3.1B | 3.1B | 3.1B | 2.6B |
Cost of Goods Sold | 2.2B | 2.6B | 2.4B | 2.5B | 2.1B |
Gross Profit | 534.2M | 520.4M | 648.7M | 604.4M | 489.1M |
Gross Margin % | 19.8% | 16.7% | 21.0% | 19.8% | 19.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 560.7M | 336.6M | 279.8M | 303.1M | 267.6M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 560.7M | 336.6M | 279.8M | 303.1M | 267.6M |
Operating Income | -111.8M | 87.4M | 276.2M | 135.0M | 102.5M |
Operating Margin % | -4.1% | 2.8% | 8.9% | 4.4% | 4.0% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 123.8M | 69.8M | 200.0K | 200.0K | - |
Other Non-Operating Income | -39.4M | -16.5M | -39.0M | 1.6M | -434.7M |
Pre-tax Income | -275.0M | 1.1M | 237.0M | 136.4M | -332.2M |
Income Tax | -3.5M | 4.5M | 44.1M | 38.4M | 27.0M |
Effective Tax Rate % | 0.0% | 409.1% | 18.6% | 28.2% | 0.0% |
Net Income | -328.5M | -3.4M | 192.9M | 98.0M | -359.2M |
Net Margin % | -12.2% | -0.1% | 6.2% | 3.2% | -13.9% |
Key Metrics | |||||
EBITDA | -3.6M | 190.7M | 371.1M | 303.4M | 657.0M |
EPS (Basic) | $-3.67 | $-0.04 | $2.18 | $1.11 | $-4.06 |
EPS (Diluted) | $-3.67 | $-0.04 | $2.18 | $1.11 | $-4.06 |
Basic Shares Outstanding | 89509537 | 88800000 | 88400000 | 88400000 | 88400000 |
Diluted Shares Outstanding | 89509537 | 88800000 | 88400000 | 88400000 | 88400000 |
Income Statement Trend
Fortrea Holdings Balance Sheet From 2021 to 2024
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Assets | ||||
Current Assets | ||||
Cash & Equivalents | 118.5M | 108.6M | 112.0M | 94.6M |
Short-term Investments | - | - | - | - |
Accounts Receivable | 156.5M | 481.0M | 449.2M | 422.5M |
Inventory | - | - | - | - |
Other Current Assets | 77.2M | 35.1M | 50.8M | 73.1M |
Total Current Assets | 948.2M | 1.3B | 1.2B | 1.1B |
Non-Current Assets | ||||
Property, Plant & Equipment | 66.2M | 78.2M | 50.0M | 65.7M |
Goodwill | 4.1B | 4.8B | 4.8B | 5.1B |
Intangible Assets | 655.7M | 771.2M | 823.3M | 935.5M |
Long-term Investments | - | - | - | - |
Other Non-Current Assets | 108.6M | 82.7M | 55.5M | 72.2M |
Total Non-Current Assets | 2.6B | 3.1B | 3.0B | 3.3B |
Total Assets | 3.6B | 4.4B | 4.3B | 4.4B |
Liabilities | ||||
Current Liabilities | ||||
Accounts Payable | 138.2M | 132.8M | 81.5M | 60.5M |
Short-term Debt | 88.2M | 45.6M | 23.3M | 24.0M |
Current Portion of Long-term Debt | - | - | - | - |
Other Current Liabilities | 39.0M | 36.0M | 27.1M | 30.2M |
Total Current Liabilities | 949.5M | 775.9M | 699.0M | 826.7M |
Non-Current Liabilities | ||||
Long-term Debt | 1.1B | 1.6B | 40.1M | 53.2M |
Deferred Tax Liabilities | 121.7M | 148.8M | 184.5M | 210.3M |
Other Non-Current Liabilities | 35.3M | 61.3M | 21.7M | 17.9M |
Total Non-Current Liabilities | 1.3B | 1.8B | 246.3M | 281.4M |
Total Liabilities | 2.2B | 2.6B | 945.3M | 1.1B |
Equity | ||||
Common Stock | 100.0K | 100.0K | 0 | - |
Retained Earnings | -397.0M | -49.1M | 0 | - |
Treasury Stock | - | - | - | - |
Other Equity | - | - | - | - |
Total Shareholders Equity | 1.4B | 1.7B | 3.3B | 3.3B |
Key Metrics | ||||
Total Debt | 1.2B | 1.7B | 63.4M | 77.2M |
Working Capital | -1.3M | 477.2M | 547.9M | 290.8M |
Balance Sheet Composition
Fortrea Holdings Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -328.5M | -3.4M | 192.9M | 98.0M | -359.2M |
Depreciation & Amortization | 86.9M | 96.4M | 92.7M | 166.3M | 119.0M |
Stock-Based Compensation | 58.4M | 42.7M | 25.4M | 27.5M | 23.1M |
Working Capital Changes | 457.1M | 18.9M | -115.1M | -154.2M | -28.3M |
Operating Cash Flow | 272.6M | 140.5M | 208.4M | 142.8M | -242.0M |
Investing Activities | |||||
Capital Expenditures | - | - | - | - | - |
Acquisitions | 276.6M | - | 0 | 0 | -137.5M |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | 277.1M | 8.5M | 400.0K | 300.0K | -137.2M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 826.5M | 1.8B | 0 | 0 | - |
Debt Repayment | -1.3B | -179.4M | 0 | 0 | - |
Financing Cash Flow | -497.8M | -139.0M | -8.7M | -128.5M | -33.1M |
Free Cash Flow | 237.3M | 127.1M | 33.1M | 143.3M | 176.9M |
Net Change in Cash | 51.9M | 10.0M | 200.1M | 14.6M | -412.3M |
Cash Flow Trend
Fortrea Holdings Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
522.33
Forward P/E
7.81
Price to Book
1.58
Price to Sales
0.34
PEG Ratio
3.13
Profitability Ratios
Profit Margin
-37.57%
Operating Margin
-1.54%
Return on Equity
-100.49%
Return on Assets
-1.42%
Financial Health
Current Ratio
1.02
Debt to Equity
210.86
Beta
1.89
Per Share Data
EPS (TTM)
$-11.39
Book Value per Share
$6.49
Revenue per Share
$30.36
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
ftre | 932.8M | 522.33 | 1.58 | -100.49% | -37.57% | 210.86 |
Vertex | 101.2B | 28.08 | 5.89 | 22.77% | 31.86% | 8.89 |
Alnylam | 61.1B | -213.71 | 244.95 | -257.83% | -12.96% | 1,093.31 |
Adaptive | 1.9B | -11.68 | 10.68 | -57.60% | -59.07% | 121.39 |
Dyne Therapeutics | 1.9B | -3.90 | 2.63 | -61.32% | 0.00% | 21.19 |
Harmony Biosciences | 1.9B | 10.45 | 2.41 | 27.58% | 23.42% | 22.43 |
Financial data is updated regularly. All figures are in the company's reporting currency.